Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-001587
Filing Date
2021-12-10
Accepted
2021-12-10 17:30:24
Documents
1
Period of Report
2021-12-08

Document Format Files

Seq Description Document Type Size
1 adicetbio_fm4dec82021.html 4  
1 adicetbio_fm4dec82021.xml 4 4899
  Complete submission text file 0000905718-21-001587.txt   6366
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SOLENO THERAPEUTICS INC. 1235 RADIO ROAD, SUITE 110 REDWOOD CITY CA 94065
Business Address
Sinclair Andrew (Reporting) CIK: 0001762451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 211486413